Description

Stryker Corporation operates as a prominent medical technology enterprise. Its business is structured into two primary divisions: Orthopaedics and Spine, and MedSurg and Neurotechnology. The Orthopaedics and Spine segment supplies critical implants for hip and knee joint replacements, alongside solutions for trauma and extremity surgeries. This division also offers a range of spinal implant systems, encompassing cervical, thoracolumbar, and interbody designs, vital for addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology segment delivers a diverse array of products tailored for numerous medical specialties. These offerings include advanced surgical equipment, navigation systems, endoscopic and communication technologies, patient handling and emergency medical apparatus, intensive care disposable items, and reprocessed medical devices. Its neurotechnology portfolio features devices for minimally invasive endovascular treatments, open brain and skull-based surgical interventions, orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation, and specialized tools for managing acute ischemic and hemorrhagic strokes. Furthermore, this segment provides craniomaxillofacial implants, such as cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its extensive product line to medical practitioners, hospitals, and various other healthcare facilities in approximately 75 nations. The company leverages a sales network comprising its own subsidiaries and branches globally, supplemented by authorized third-party dealers and distributors. Founded in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.